Microbiota-Targeted Intervention Decreases IHTC in Patients With NAFLD
The clinical trial compared outcomes in patients with NAFLD on a resistant starch diet to a control group over a 4-month period, with results suggesting microbiota dietary supplements may improve liver conditions.